[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Hydrocephalus Shunts - Medical Devices Pipeline Assessment, 2019

December 2019 | 87 pages | ID: HB6ACCC9C7D8EN
GlobalData

US$ 4,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
Hydrocephalus Shunts - Medical Devices Pipeline Assessment, 2019

SUMMARY

GlobalData's Medical Devices sector report, “Hydrocephalus Shunts - Medical Devices Pipeline Assessment, 2019' provides an overview of Hydrocephalus Shunts currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Hydrocephalus Shunts pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

SCOPE
  • Extensive coverage of the Hydrocephalus Shunts under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Hydrocephalus Shunts and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
REASONS TO BUY

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Hydrocephalus Shunts under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date
1.2 List of Figures
2.1 Hydrocephalus Shunts Overview

3 PRODUCTS UNDER DEVELOPMENT

3.1 Hydrocephalus Shunts - Pipeline Products by Stage of Development
3.2 Hydrocephalus Shunts - Pipeline Products by Segment
3.3 Hydrocephalus Shunts - Pipeline Products by Territory
3.4 Hydrocephalus Shunts - Pipeline Products by Regulatory Path
3.5 Hydrocephalus Shunts - Pipeline Products by Estimated Approval Date
3.6 Hydrocephalus Shunts - Ongoing Clinical Trials

4 HYDROCEPHALUS SHUNTS - PIPELINE PRODUCTS UNDER DEVELOPMENT BY COMPANIES

4.1 Hydrocephalus Shunts Companies - Pipeline Products by Stage of Development
4.2 Hydrocephalus Shunts - Pipeline Products by Stage of Development

5 HYDROCEPHALUS SHUNTS COMPANIES AND PRODUCT OVERVIEW

5.1 Arkis BioSciences Company Overview
  5.1.1 Arkis BioSciences Pipeline Products & Ongoing Clinical Trials Overview
5.2 Beckersmith Medical, Inc. Company Overview
  5.2.1 Beckersmith Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.3 Biosan Medical Ltd. Company Overview
  5.3.1 Biosan Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview
5.4 CereVasc LLC Company Overview
  5.4.1 CereVasc LLC Pipeline Products & Ongoing Clinical Trials Overview
5.5 CSF-Dynamics AS Company Overview
  5.5.1 CSF-Dynamics AS Pipeline Products & Ongoing Clinical Trials Overview
5.6 Georgia Institute of Technology Company Overview
  5.6.1 Georgia Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview
5.7 H-Cubed Inc. Company Overview
  5.7.1 H-Cubed Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.8 Integra LifeSciences Holdings Corp Company Overview
  5.8.1 Integra LifeSciences Holdings Corp Pipeline Products & Ongoing Clinical Trials Overview
5.9 Johns Hopkins University Company Overview
  5.9.1 Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview
5.10 Leucadia Therapeutics Company Overview
  5.10.1 Leucadia Therapeutics Pipeline Products & Ongoing Clinical Trials Overview
5.11 Microbot Medical Ltd Company Overview
  5.11.1 Microbot Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.12 Monitor Med Solutions Company Overview
  5.12.1 Monitor Med Solutions Pipeline Products & Ongoing Clinical Trials Overview
5.13 NeuraMedica, LLC Company Overview
  5.13.1 NeuraMedica, LLC Pipeline Products & Ongoing Clinical Trials Overview
5.14 NexGen Medical Systems Inc Company Overview
  5.14.1 NexGen Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview
5.15 Sree Chitra Tirunal Institute for Medical Sciences & Technology Company Overview
  5.15.1 Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview
5.16 System Science Inc. Company Overview
  5.16.1 System Science Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.17 University Hospital Zurich Company Overview
  5.17.1 University Hospital Zurich Pipeline Products & Ongoing Clinical Trials Overview
5.18 University of California Los Angeles Company Overview
  5.18.1 University of California Los Angeles Pipeline Products & Ongoing Clinical Trials Overview
5.19 University of Iowa Company Overview
  5.19.1 University of Iowa Pipeline Products & Ongoing Clinical Trials Overview
5.20 University of Rochester Company Overview
  5.20.1 University of Rochester Pipeline Products & Ongoing Clinical Trials Overview
5.21 University of South Florida Company Overview
  5.21.1 University of South Florida Pipeline Products & Ongoing Clinical Trials Overview
5.22 University of Wisconsin Madison Company Overview
  5.22.1 University of Wisconsin Madison Pipeline Products & Ongoing Clinical Trials Overview
5.23 Vivonics Inc Company Overview
  5.23.1 Vivonics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.24 Wayne State University Company Overview
  5.24.1 Wayne State University Pipeline Products & Ongoing Clinical Trials Overview

6 HYDROCEPHALUS SHUNTS- RECENT DEVELOPMENTS

6.1 Nov 19, 2019: Medtronic reports second quarter financial results for the year 2019
6.2 Nov 14, 2019: Medtronic highlights leadership in inclusion, diversity, and equity in 2019 integrated performance report
6.3 Nov 04, 2019: CereVasc receives approval to initiate first-in-human clinical study of the eShunt System
6.4 Oct 24, 2019: Integra LifeSciences reports third quarter 2019 financial results
6.5 Oct 23, 2019: LeMaitre Vascular announces Q3 2019 financial results

7 APPENDIX

7.1 Methodology
7.2 About GlobalData
7.3 Contact Us
7.4 Disclaimer

LIST OF TABLES

Table 1: Hydrocephalus Shunts - Pipeline Products by Stage of Development
Table 2: Hydrocephalus Shunts - Pipeline Products by Segment
Table 3: Hydrocephalus Shunts - Pipeline Products by Territory
Table 4: Hydrocephalus Shunts - Pipeline Products by Regulatory Path
Table 5: Hydrocephalus Shunts - Pipeline Products by Estimated Approval Date
Table 6: Hydrocephalus Shunts - Ongoing Clinical Trials
Table 7: Hydrocephalus Shunts Companies - Pipeline Products by Stage of Development
Table 8: Hydrocephalus Shunts - Pipeline Products by Stage of Development
Table 9: Arkis BioSciences Pipeline Products & Ongoing Clinical Trials Overview
Table 10: Arkis AutoShunt - Product Status
Table 11: Arkis AutoShunt - Product Description
Table 12: Beckersmith Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 13: FlowSafe - Product Status
Table 14: FlowSafe - Product Description
Table 15: Biosan Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview
Table 16: Ventritek105 - Product Status
Table 17: Ventritek105 - Product Description
Table 18: CereVasc LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 19: eShunt - Product Status
Table 20: eShunt - Product Description
Table 21: CereVasc LLC - Ongoing Clinical Trials Overview
Table 22: eShunt - Endovascular Treatment of Communicating Hydrocephalus with the eShunt System
Table 23: CSF-Dynamics AS Pipeline Products & Ongoing Clinical Trials Overview
Table 24: SinuShunt - Product Status
Table 25: SinuShunt - Product Description
Table 26: Georgia Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview
Table 27: Hydrocephalus Shunt - Product Status
Table 28: Hydrocephalus Shunt - Product Description
Table 29: H-Cubed Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 30: Ambulatory System For Hydrocephalus Shunt - Product Status
Table 31: Ambulatory System For Hydrocephalus Shunt - Product Description
Table 32: Integra LifeSciences Holdings Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 33: Codman Certas Plus Electronic Tool Kit - Product Status
Table 34: Codman Certas Plus Electronic Tool Kit - Product Description
Table 35: CSF Management Device - Product Status
Table 36: CSF Management Device - Product Description
Table 37: Hydrocephalic Shunt - Product Status
Table 38: Hydrocephalic Shunt - Product Description
Table 39: Ventricular Drainage Device - Product Status
Table 40: Ventricular Drainage Device - Product Description
Table 41: Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview
Table 42: CADENCE Balloon Shunt - Product Status
Table 43: CADENCE Balloon Shunt - Product Description
Table 44: Leucadia Therapeutics Pipeline Products & Ongoing Clinical Trials Overview
Table 45: Arethusta - Product Status
Table 46: Arethusta - Product Description
Table 47: Microbot Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 48: Self-Cleaning Shunt (SCS) Shunt Catheter - Product Status
Table 49: Self-Cleaning Shunt (SCS) Shunt Catheter - Product Description
Table 50: Microbot Medical Ltd - Ongoing Clinical Trials Overview
Table 51: Self-Cleaning Shunt (SCS) Shunt Catheter - Clinical Investigation of Self-Cleaning Shunt (SCS) Device
Table 52: Monitor Med Solutions Pipeline Products & Ongoing Clinical Trials Overview
Table 53: Hydrocephalus Shunt System - Product Status
Table 54: Hydrocephalus Shunt System - Product Description
Table 55: NeuraMedica, LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 56: Dural Clip - Product Status
Table 57: Dural Clip - Product Description
Table 58: NexGen Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 59: EViTAR FLOWMETER - Product Status
Table 60: EViTAR FLOWMETER - Product Description
Table 61: Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview

LIST OF FIGURES

Figure 1: Hydrocephalus Shunts - Pipeline Products by Stage of Development
Figure 2: Hydrocephalus Shunts - Pipeline Products by Segment
Figure 3: Hydrocephalus Shunts - Pipeline Products by Territory
Figure 4: Hydrocephalus Shunts - Pipeline Products by Regulatory Path
Figure 5: Hydrocephalus Shunts - Pipeline Products by Estimated Approval Date
Figure 6: Hydrocephalus Shunts - Ongoing Clinical Trials

COMPANIES MENTIONED

Arkis BioSciences
Beckersmith Medical, Inc.
Biosan Medical Ltd.
CereVasc LLC
CSF-Dynamics AS
Georgia Institute of Technology
H-Cubed Inc.
Integra LifeSciences Holdings Corp
Johns Hopkins University
Leucadia Therapeutics
Microbot Medical Ltd
Monitor Med Solutions
NeuraMedica, LLC
NexGen Medical Systems Inc
Sree Chitra Tirunal Institute for Medical Sciences & Technology
System Science Inc.
University Hospital Zurich
University of California Los Angeles
University of Iowa
University of Rochester
University of South Florida
University of Wisconsin Madison
Vivonics Inc
Wayne State University


More Publications